DNA synthesis is a pivotal aspect of biopharmaceutics, playing a crucial role in the development of advanced therapies and drugs. This intricate process involves the creation of artificial genes or DNA sequences, often customized for therapeutic purposes. The precision of DNA synthesis is paramount, ensuring the accurate replication of genetic material for applications such as gene therapy and the production of biopharmaceuticals.
In the realm of biopharmaceutics, DNA synthesis serves as the foundation for the design and production of recombinant proteins, monoclonal antibodies, and other biologics. This technology enables scientists to engineer specific genetic sequences, tailoring therapeutic agents to target precise molecular pathways. The advancements in DNA synthesis techniques have significantly contributed to the rapid evolution of biopharmaceutical research and development, fostering innovation in precision medicine.
As biopharmaceutics continues to push the boundaries of medical science, DNA synthesis stands at the forefront, driving breakthroughs that hold the promise of more targeted, effective, and personalized therapeutic interventions. The convergence of biotechnology and pharmaceuticals in the realm of DNA synthesis underscores its integral role in shaping the future of healthcare.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia